External-filtration and internal-absorption quaternary ammonium salt chitosan nanofiber hemostatic sponge and preparation method thereof

Quaternary ammonium salt chitosan nanofiber hemostatic sponge prepared by electrospinning and ice template freeze-drying technology uses gradient pore structure and electrostatic attraction mechanism to solve the insufficient performance of existing hemostatic materials in incompressible bleeding scenarios. Achieve rapid and effective hemostasis effect.

CN118978737APending Publication Date: 2024-11-19NORTHWEST UNIV
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411075148.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-07
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The existing hemostatic materials lack hemostatic performance in incompressible bleeding scenarios, especially the low liquid absorption ratio of sponge materials, resulting in limited ability to concentrate coagulation components, and it is impossible to effectively control deep and irregular bleeding.

Method used

The quaternary ammonium salt chitosan nanofiber hemostatic sponge with gradient pore structure was prepared by electrospinning technology and ice template freeze-drying technology. The synergistic mechanism of small pore filtration on the outer surface and large pores in the internal large pores are quickly absorbed and screened in the blood. the blood clots form blood clots.

Benefits of technology

It achieves rapid hemostasis for incompressible bleeding, independent of the body's coagulation cascade, is not affected by coagulation disorders, has ultra-high fluid absorption ratio and excellent structural stability, significantly shortening the hemostasis time.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118978737A_ABST
    Figure CN118978737A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of medical material preparation, in particular to external-filtration and internal-absorption quaternary ammonium salt chitosan nanofiber hemostatic sponge and a preparation method thereof. The method comprises the following steps: preparing a chitosan nanofiber membrane by using electrostatic spinning equipment; then, the chitosan nanofiber membrane is homogenized, and chitosan nanofiber turbid liquid is obtained; finally, adding 2, 3-epoxypropyl trimethyl ammonium chloride into the turbid liquid, and carrying out a heating reaction to obtain quaternary ammonium salt grafted chitosan nanofibers; and then preparing the quaternary ammonium salt chitosan nanofiber into turbid liquid, freezing by utilizing a low-temperature cold source, and freeze-drying to obtain the quaternary ammonium salt chitosan nanofiber hemostatic sponge. The nanofiber hemostatic sponge obtained by the invention has the characteristics of small holes in the outer surface and large holes in the inner part, and is beneficial to concentration of a large number of blood coagulation components so as to realize rapid hemostasis of incompressible hemorrhage.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of medical material preparation, and in particular to a chitosan nanofiber hemostatic sponge for external filtration and internal absorption of quaternary ammonium salt and a preparation method thereof. Background Art

[0002] With the development of medical technology, emergency medical rescue has been vigorously developed. However, excessive bleeding is still the main cause of casualties at the emergency scene. Therefore, effective pre-hospital bleeding control is the primary goal at the emergency scene and an important guarantee for improving the survival rate of the wounded. Effective bleeding control can delay blood loss and buy time for further rescue. In injuries caused by war, traffic accidents, disasters or other accidents, special parts of the body such as the limb-trunk junction (neck, armpits, groin, etc.) and the trunk (chest, abdomen and pelvis, etc.) are extremely vulnerable to injury, forming deep, irregular incompressible bleeding. Incompressible bleeding accounts for 90% of deaths from traumatic injuries in war and 30%-40% of civilian deaths. Therefore, effective control of incompressible bleeding is an urgent problem to be solved at the emergency scene, and solving this problem usually involves hemostatic materials. Hemostatic materials can be divided into two categories:

[0003] (1) Active hemostatic materials. This type of material achieves the purpose of hemostasis mainly by accelerating the formation of platelet plugs in the primary coagulation stage and the formation of fibrin networks in the secondary coagulation stage. For example, fibrin glue, thrombin preparations, kaolin and montmorillonite preparations accelerate the activation and aggregation of platelets, thereby accelerating the formation of platelet plugs or regulating coagulation factors to accelerate the formation of fiber networks to promote coagulation. The biggest problem with active hemostatic materials is that once they enter the blood vessels, they will cause systemic thrombosis, and they rely heavily on the body's own coagulation system to exert a hemostatic effect, which poses a great challenge to patients with coagulation disorders. In addition, biochemical products such as fibrin, collagen, and thrombin usually have problems such as harsh storage conditions, short shelf life, high prices, and immunogenicity, which limits their widespread application.

[0004] (2) Passive hemostatic materials mainly stop bleeding wounds through the physical effects of materials, including absorbing blood to concentrate coagulation components, aggregating and adhering coagulation components, and forming a physical barrier at the bleeding wound. Since passive hemostatic materials can be independent of the body's coagulation cascade reaction and blood diseases, their wide applicability and compatibility with biochemical strategies are ensured. Due to the universality of passive hemostatic materials and the characteristics of incompressible bleeding, hemostatic materials for incompressible bleeding can be divided into hemostatic particles (hemostatic powder), hemostatic glue (hemostatic adhesive) and hemostatic sponges according to the specifications of the materials. Among them, the advantage of sponge hemostatic materials is that they can be directly applied to the bleeding wound site, even the internal site, and can promote hemostasis through mechanisms such as liquid absorption and concentration, physical blocking, etc. However, most of the current sponge hemostatic materials rely on simple physical blocking and liquid absorption and concentration mechanisms for hemostasis. And due to the low liquid absorption rate, the ability to concentrate coagulation components is limited, and the hemostatic performance for incompressible bleeding is weak. Therefore, it is an urgent problem to develop a new generation of hemostatic sponges with excellent hemostatic ability for incompressible bleeding. Summary of the invention

[0005] The invention aims to provide a chitosan nanofiber hemostatic sponge capable of external filtration and internal absorption of quaternary ammonium salt and a preparation method thereof.

[0006] The implementation process of the present invention is as follows:

[0007] A chitosan nanofiber hemostatic sponge with external filtration and internal absorption of quaternary ammonium salt and a preparation method thereof, comprising the following steps:

[0008] (1) Preparation of chitosan nanofiber membrane

[0009] The chitosan is dissolved in a mixed solvent of hexafluoroisopropanol and glacial acetic acid to obtain a chitosan spinning solution; the chitosan spinning solution is electrostatically spun using an electrostatic spinning device, and nanofibers are collected and dried to obtain a chitosan nanofiber membrane;

[0010] (2) Preparation of quaternary ammonium salt chitosan nanofiber hemostatic sponge

[0011] The chitosan nanofiber membrane obtained in step (1) is homogenized to obtain a chitosan short fiber suspension; 2,3-epoxypropyltrimethylammonium chloride is added to the chitosan short fiber suspension for heating reaction, and quaternary ammonium salt-grafted chitosan nanofibers are obtained by centrifugation; the quaternary ammonium salt-grafted chitosan nanofibers are added with a solvent to prepare a suspension, and then the suspension is poured into a container and frozen using a low-temperature cold source, and after complete freezing, it is transferred to a vacuum freeze dryer and freeze-dried to obtain a quaternary ammonium salt chitosan nanofiber hemostatic sponge.

[0012] Furthermore, in step (1), the volume ratio of hexafluoroisopropanol to glacial acetic acid is (8-9):(1-2).

[0013] Furthermore, in step (1), the mass volume ratio of chitosan to the mixed solvent is (0.2-1.0) g:10 mL.

[0014] Furthermore, in step (1), the chitosan spinning solution is electrospun at room temperature using an electrospinning device.

[0015] Furthermore, in step (1), during the electrospinning process, the spinning flow rate is (0.1-2.0) mL / h; the spinning voltage is (5-30) kV; the roller speed is (100-4000) r / min; the spinning distance is (5-20) cm from the needle to the roller; and the nanofibers are collected using aluminum foil attached to the roller.

[0016] Furthermore, in step (2), the solvent for homogenizing the chitosan nanofiber membrane is water, wherein the mass volume ratio of the chitosan nanofiber membrane to the solvent is (0.1-10.0) g:50 mL; and the molar ratio of 2,3-epoxypropyltrimethylammonium chloride to the chitosan short fibers in the chitosan short fiber suspension is 2:(0.5-1).

[0017] Furthermore, in step (2), the temperature of the heating reaction is 60-85° C., and the reaction time is 1-40 hours; in the process of adding the quaternary ammonium salt-grafted chitosan nanofibers into a solvent to prepare a suspension, the solid content of the suspension is 0.1%-10.0%, and the solvent is water; the low-temperature cooling source is liquid nitrogen.

[0018] Furthermore, the method also includes placing the obtained quaternary ammonium salt chitosan nanofiber hemostatic sponge in the steam of 1% to 50% by mass of glutaraldehyde solution for cross-linking, so that the fibers inside the sponge overlap with each other to improve the stability of the structure, and then vacuum drying the sponge to remove the residual glutaraldehyde solution steam in the sponge, so as to obtain a quaternary ammonium salt chitosan nanofiber hemostatic sponge with a more stable structure.

[0019] The quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained by the above method has a gradient pore structure with different pore diameters inside and outside.

[0020] Furthermore, the outer surface of the quaternary ammonium chitosan nanofiber hemostatic sponge contains a large number of small pore structures formed by randomly arranged quaternary ammonium chitosan nanofibers overlapping each other, and the external small pores can filter coagulation components; the internal structure of the quaternary ammonium chitosan nanofiber hemostatic sponge is a large number of large pore structures, and the internal large pores make the hemostatic sponge have an ultra-high liquid absorption rate.

[0021] The working principle of the external filtration and internal absorption quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained by the method of the present invention is as follows:

[0022] By imitating the structure and function of the fibrin network in the blood clot, a quaternary ammonium salt chitosan nanofiber hemostatic sponge with a gradient pore structure of small pores on the outer surface: 4.9μm, large pores on the inner surface: 22.6μm and a high liquid absorption rate (93g / g) was prepared by using electrostatic spinning technology and ice template freeze drying technology. When the nanofiber hemostatic sponge of the present invention acts on a deep incompressible bleeding wound, firstly, due to the high liquid absorption characteristics of the sponge, the plasma in the blood will be quickly absorbed to achieve the purpose of aggregating platelets and red blood cells. Then, on the one hand, due to the small pore structure on the outer surface and the macroporous structure that is interconnected inside, the coagulation components (mainly red blood cells, platelets, etc.) in the blood will be screened and filtered. The coagulation components are further captured and aggregated on the outer surface of the nanofiber hemostatic sponge, and the plasma filtered into the inside of the nanofiber hemostatic sponge is stored in the macroporous structure inside the nanofiber hemostatic sponge. On the other hand, due to the grafting of quaternary ammonium salt, the electrostatic attraction of the outer surface of the nanofiber hemostatic sponge is further enhanced, so that the coagulation components are gathered on the outer surface of the nanofiber hemostatic sponge. Through the synergistic effect of the above multiple mechanisms, a large amount of coagulation components will be gathered on the surface of the nanofiber hemostatic sponge, and then blood clots will be formed quickly, achieving rapid hemostasis to incompressible bleeding. Compared to traditional coagulation mechanism, the nanofiber hemostatic sponge of the present invention can form blood clots quickly to stop bleeding, and is independent of the body's coagulation cascade reaction, is not affected by blood diseases such as coagulation disorders, so that it can be widely used in various types of wound bleeding.

[0023] Positive effects of the present invention:

[0024] (1) The present invention adopts the strategy of structural bionics and functional bionics, and uses electrospinning technology and ice template freeze-drying technology to prepare a bionic nanofiber hemostatic sponge with a gradient pore structure. The obtained nanofiber hemostatic sponge has a unique gradient pore characteristic, that is, small pores on the outer surface and large pores inside, and has a synergistic hemostatic mechanism of external "filtration (filtering coagulation components)" and internal "absorption (ultra-high liquid absorption rate)", which helps to concentrate a large amount of coagulation components to achieve rapid hemostasis of incompressible bleeding.

[0025] (2) The quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained by the method of the present invention has a gradient pore structure with 4.9 μm small pores on the outer surface and 22.6 μm large pores inside. The results of the liquid absorption experiment show that the nanofiber sponge has an ultra-high liquid absorption capacity, and the absorption rates of water and blood are about 93 and 73 g / g, respectively. The sponge shows excellent structural stability and elasticity, and can still restore its original morphology after 10 cycles of compression.

[0026] (3) The results of in vitro and in vivo hemostasis experiments show that the external filtration and internal absorption quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained by the method of the present invention has excellent in vitro coagulation performance and can efficiently screen and filter red blood cells with a filtration efficiency of up to 91.2%. In the rat liver defect bleeding model (incompressible bleeding model), the external filtration and internal absorption quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained by the method of the present invention can shorten the hemostasis time by about 2.5 times compared with the commercial gelatin hemostatic sponge. In the rabbit aorta injury bleeding model (lethal carotid artery bleeding model), the external filtration and internal absorption quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained by the method of the present invention showed excellent hemostatic ability and could effectively control bleeding in about 61.6s, while the commercial gelatin hemostatic sponge still could not control bleeding at 240s. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 Characterization of chitosan nanofiber membrane; (a) photo of chitosan nanofiber membrane; (b) SEM image of chitosan nanofiber membrane; (c) nanofiber diameter distribution; (d) water contact angle of chitosan nanofiber membrane; (e) photo of chitosan nanofiber membrane after dripping water; (f) photo of chitosan short fiber suspension; (g) optical microscope photo of chitosan short fiber suspension; (h) length statistics of chitosan short fibers in the suspension;

[0028] Figure 2 Characterization of quaternary ammonium chitosan nanofiber hemostatic sponge with gradient pore structure; (a) ultra-light property and ultra-high porosity of quaternary ammonium chitosan nanofiber hemostatic sponge; (bd) SEM images of the outer surface and inner structure of quaternary ammonium chitosan nanofiber hemostatic sponge; (e) average pore size of the outer surface and inner structure of quaternary ammonium chitosan nanofiber hemostatic sponge; (f) FTIR spectra of 2,3-epoxypropyltrimethylammonium chloride and quaternary ammonium chitosan nanofiber hemostatic sponge;

[0029] Figure 3 The liquid absorption performance of the quaternary ammonium salt chitosan nanofiber hemostatic sponge; wherein, (a, b) the change of the contact angle of the sponge to water and blood; (c, d) the liquid absorption process of the sponge to water and blood; (e) the reabsorption process of the sponge; (f) the water / blood absorption ratio of the sponge; (g) the liquid reabsorption performance of the sponge;

[0030] Figure 4 This is a diagram of the compression and recovery process of the quaternary ammonium salt chitosan nanofiber hemostatic sponge;

[0031] Figure 5The quaternary ammonium chitosan nanofiber hemostatic sponge is a performance diagram for filtering and capturing red blood cells; wherein, (ab) surface and internal SEM images of the quaternary ammonium chitosan nanofiber hemostatic sponge after filtering red blood cells; (c) schematic diagram of the filter capture of red blood cells by the quaternary ammonium chitosan nanofiber hemostatic sponge; (d) filter capture and coagulation process of the quaternary ammonium chitosan nanofiber hemostatic sponge in whole blood;

[0032] Figure 6 This is a study on the in vitro antibacterial properties of quaternary ammonium salt chitosan nanofiber hemostatic sponge; (a) photos of the colony growth of Staphylococcus aureus and Escherichia coli; (b, c) antibacterial efficiency against Staphylococcus aureus and Escherichia coli;

[0033] Figure 7 The hemostatic performance of quaternary ammonium chitosan nanofiber hemostatic sponge on bleeding models; including: (a) rabbit carotid artery bleeding model; (b) bleeding condition after treatment; (c) hemostasis time; (d) blood loss. DETAILED DESCRIPTION

[0034] The present invention is further described below in conjunction with the embodiments.

[0035] Example 1

[0036] 1. Preparation method of chitosan nanofiber hemostatic sponge with external filtration and internal absorption of quaternary ammonium salt

[0037] (1) Preparation of chitosan nanofiber membrane

[0038] 0.2g chitosan particles were added to 10mL mixed solvent of hexafluoroisopropanol (HFIP) and glacial acetic acid (HAC) in a ratio of 9:1 and stirred for 12h to obtain a translucent chitosan spinning solution. The chitosan spinning solution was electrospun at room temperature using an electrospinning device, with a spinning flow rate of 1.2mL / h; a spinning voltage of 18kV; a roller speed of 500r / min, and a spinning distance of 15cm from the needle to the roller. The nanofibers were collected using aluminum foil attached to the roller, and the non-volatile solvent was removed by vacuum drying in an oven to obtain a uniform chitosan nanofiber membrane. The experiment was repeated many times to obtain a large number of chitosan nanofiber membranes.

[0039] (2) Preparation of quaternary ammonium salt chitosan nanofiber hemostatic sponge

[0040] After adding 50 mL of water to 0.5 g of the chitosan nanofiber membrane obtained in step (1), it was crushed and homogenized to obtain a uniform and stable chitosan short fiber suspension. Then, the chitosan nanofiber was grafted with quaternary ammonium salt, and 0.2 mol of 2,3-epoxypropyltrimethylammonium chloride (GTMAC) solid powder was added to the short fiber suspension with a chitosan nanofiber content of 0.1 mol in a molar ratio, and reacted at 80 ° C for 36 hours. Then, a centrifuge was used to centrifuge at 6000 rpm for 10 minutes to remove the unreacted 2,3-epoxypropyltrimethylammonium chloride (GTMAC) to obtain quaternary ammonium salt-grafted chitosan nanofibers. The quaternary ammonium salt-grafted chitosan nanofibers and solvent water were further prepared into a suspension with a solid content of 1%, which was poured into a container and frozen with liquid nitrogen until it became a block. Then be transferred to the quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained by freeze drying in the vacuum freeze drier, the outer surface of the quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained contains a large amount of pores, and these pores are composed of the mutual overlap of randomly arranged nanofibers, and internal structure is a very large hole.Placing the quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained in mass percent is cross-linked in 50% glutaraldehyde solution steam, making the mutual overlap between the fiber inside the sponge improve the stability of structure, then sponge is removed residual glutaraldehyde solution steam in the sponge through vacuum drying, obtain the quaternary ammonium salt chitosan nanofiber hemostatic sponge with more stable structure.

[0041] 2.1 Structure and composition characterization

[0042] (1) Morphological characterization: The short fiber suspension after homogenization was observed using an optical microscope, and the length of the nanofibers was measured using Image J. The lengths of 50 short fibers were measured and the average length was calculated. The microscopic morphology of the chitosan nanofiber membrane and the quaternary ammonium chitosan nanofiber hemostatic sponge was observed using a scanning electron microscope (SEM). The samples were cut into appropriate sizes and placed on the sample table. They were observed using SEM after gold spraying. The outer surface and internal pore size of the quaternary ammonium chitosan nanofiber hemostatic sponge were measured using Image J. 50 outer surface pore sizes and internal pore sizes were measured, and the average pore size was calculated.

[0043] (2) Functional group characterization: The composition of the sample was tested and analyzed using Fourier transform infrared spectroscopy (FTIR). 0.2 g of quaternary ammonium salt chitosan nanofiber hemostatic sponge and 1.0 g of potassium bromide particles were mixed and ground into powder using a mortar, and then tested and analyzed by tableting.

[0044] (3) Porosity: The porosity of the sponge was measured by the volume displacement method. The sponge was cut into a column with a diameter of 1 cm and a height of 0.5 cm, and weighed using an electronic balance to obtain the dry mass M0. The sponge was immersed in anhydrous ethanol (ρ = 0.789 g / cm 3 ) for 10 minutes to allow the sponge to absorb saturated liquid, gently take out the sample after absorbing liquid and weigh it using an electronic balance to obtain the wet mass M1. Calculate the volume (V) of the sponge and calculate the porosity of the sponge using the following formula.

[0045] P=[(M1-M0) / (ρ×V)]×100% (1)

[0046] Where M0 is the mass of the sample in a dry state (g); M1 is the mass of the sample after absorbing ethanol (g); V is the volume of the sample in a dry state (cm 3 );ρ is the density of anhydrous ethanol (g / cm 3 ); Each sample was measured 3 times and the average value was taken.

[0047] (4) Density: The density of the sponge is obtained by measuring and calculating the volume and mass of the sponge. Cut the sponge into 1 cm diameter and 0.5 cm height, calculate the volume V of the sponge, and weigh the sponge using an electronic balance to obtain M. The density of the sponge is calculated using the following formula.

[0048] P=M / V (2)

[0049] Where V is the volume of the sponge (cm 3 ); M is the mass of the sponge (mg); each group of samples was measured 3 times in parallel and the average value was taken.

[0050] 2.2 Determination of the liquid absorption performance of quaternary ammonium chitosan nanofiber hemostatic sponge

[0051] (1) Preparation of phosphate buffer solution (PBS): Use an electronic balance to weigh 0.1 g KCl, 0.1 g KH2PO4, 1.5 g Na2HPO4·12H2O, and 4.0 g NaCl, add to 500 mL distilled water, stir evenly, and adjust the pH of the solution to 7.4 for later use.

[0052] (2) Hydrophilicity test: The water contact angle changes of the samples were tested using a static contact angle tester (WCA). The sponges were cut into the same thickness and placed on a glass slide. 3 μL of deionized water was vertically dripped on the sample surface, and the contact angle changes were observed and recorded.

[0053] (3) Liquid absorption rate test: Sponges were cut into the same size (1 cm in diameter and 2 cm in height), placed in deionized water stained with methylene blue, and the liquid transfer process was observed. The time it took for the sponge to transfer the methylene blue solution from the bottom to the top of the sponge was calculated, and each group of sponges was measured 3 times and the average value was taken.

[0054] (4) Liquid absorption rate test: Cut the samples into the same size (1 cm in diameter and 0.5 cm in height), calculate the sample volume as V, and record its initial weight M0. Then soak it in distilled water and PBS buffer for about 5 min to allow the sponge to absorb the liquid completely. Gently take it out and weigh the sponge after absorption using an electronic balance to obtain the mass M0. t , the liquid absorption performance of the sample is calculated by the following formula.

[0055] Wm= (M t -M0) / M0 (3)

[0056] Where Wm is the liquid absorption rate per unit mass of the sponge (g / g); M0 is the mass of the sponge before absorbing the liquid (g); t is the mass of the sponge after absorbing the liquid (g); each group of sponges was measured 3 times and the average value was taken.

[0057] (5) Shape recovery rate of sponges after liquid absorption: Sponges were cut into the same size (1 cm in diameter and 1 cm in height) and compressed to 20% of their original volume. The compressed sponges were then placed in deionized water to observe the shape recovery of the sponges after liquid absorption. The volume recovery ratios of the sponges at different time points were calculated, and the average value was taken for each group of sponges after 3 measurements.

[0058] (6) Liquid reabsorption capacity test: Cut the samples into the same size (1 cm in diameter and 0.5 cm in height), calculate the sample volume as V, and record its initial weight. Then soak it in distilled water and PBS buffer for about 5 min to allow the sponge to be completely absorbed and saturated. Gently take it out and weigh the sponge after absorbing liquid using an electronic balance. After weighing, press it to 20% of the original height to squeeze out some distilled water and weigh it again. After completion, put it back into distilled water to allow it to completely absorb liquid again and weigh it. Repeat this process and weigh the mass of the sponge after squeezing out water and reabsorbing liquid, and calculate the liquid absorption rate. The whole process is repeated 10 times.

[0059] 2.3 Determination of mechanical properties of quaternary ammonium salt chitosan nanofiber hemostatic sponge

[0060] The mechanical properties of the sponge were evaluated by compression test and compression cycle test using a universal mechanical testing machine. The sponge was prepared into a cylinder with a diameter of 1 cm and a height of 1 cm, and the compression speed was set to 5 mm / min. In the compression test, the cylindrical sponge was compressed to a strain of 80%. When compressing different strains, the sponge was compressed to strains of 20%, 40%, 60%, and 80% respectively, and recovered to a strain of 0% at the same speed. In cyclic compression, the sponge was compressed to a strain of 80% in dry and wet states, and then recovered to a strain of 0% at the same speed, and the number of cycles was 10.

[0061] 2.4 Evaluation of antibacterial effect

[0062] The antibacterial properties of the sponge were tested by the plate counting method using Staphylococcus aureus and Escherichia coli. The control group was treated without any treatment, and the QCS quaternary ammonium salt chitosan nanofiber hemostatic sponge was used as the experimental group. After thawing, the Staphylococcus aureus strain and the Escherichia coli strain were diluted to 1x10 6 CFUs / mL is reserved. Place the same volume of sponge in a 24-well plate, take 1mL of the above concentration of Staphylococcus aureus and Escherichia coli solution and add it to the well plate where the sponge sample is placed, and incubate it in a constant temperature biochemical incubator at 37°C for 24 hours. After the predetermined time is reached, take 100μL of the co-cultured bacterial solution and dilute it to TSA plate, incubate it in a constant temperature biochemical incubator at 37°C for 24 hours, and then count it. The antibacterial properties of all sponges are evaluated by colony forming units. The antibacterial rate can be calculated as follows.

[0063] Bacterial inhibition rate (%) = (B r -B s ) / B r ×100%(4)

[0064] Among them B r is the number of surviving bacterial colonies in the blank group, B s is the number of surviving bacterial colonies in the sample group.

[0065] 2.5 Establishment of in vivo hemostasis model

[0066] The in vivo hemostatic properties of the sponge were tested using a rabbit carotid artery bleeding model.

[0067] New Zealand rabbits (2.5±0.5kg) were randomly divided into 3 groups, 4 in each group. After anesthesia, they were fixed on the operating table in a supine position. After hair removal and disinfection, the neck was cut about 2cm to expose the right carotid artery. A pre-weighed medical skin patch and a blood collection bag were pasted, and 1mm on the artery was cut, not completely cut off to ensure normal blood loss. Commercial gelatin hemostatic sponges and collagen hemostatic sponges were used as the control group, and QCS quaternary ammonium salt chitosan nanofiber hemostatic sponges were used as the experimental group. A syringe was used to inject the pre-weighed hemostatic sponge into the bleeding wound for hemostasis. The wound was covered with medical gauze to absorb the exuded blood, and the bleeding was observed. After the medical gauze was soaked, a new medical gauze was replaced, and 4min was the observation end point for hemostasis. Within 4min, there was no obvious bleeding or bleeding in the wound, which was recorded as successful hemostasis, and the hemostasis time was recorded. After 4min, there was still bleeding, which was recorded as failed hemostasis. Observe the bleeding of the wound, record the bleeding time and blood loss.

[0068] 2.6 Statistical analysis

[0069] All experiments and data were tested at least three times, and the quantitative data results were expressed as mean ± standard deviation. One-way ANOVA was performed using Graphpad software. P ≤ 0.05 was considered statistically significant and marked with *; P ≤ 0.01 was marked with **; P ≤ 0.001 was marked with ***; P ≤ 0.0001 was marked with ****.

[0070] 3 Results and discussion

[0071] 3.1 Structure and composition of chitosan nanofiber membrane

[0072] Chitosan nanofiber membrane photos Figure 1 a; SEM photo of chitosan nanofiber membrane Figure 1 b, the results show that the chitosan nanofiber membrane has uniform fiber thickness and regular arrangement. The diameter of the chitosan nanofibers in the SEM image was measured, and the average diameter was 0.19±0.04μm ( Figure 1 c); from Figure 1 The water contact angle of the chitosan nanofiber membrane obtained in d is 36°, indicating that the chitosan nanofiber membrane has good hydrophilicity; PBS solution was added to the surface of the chitosan nanofiber membrane, and the stability of the nanofiber was evaluated by the state of the fiber membrane ( Figure 1 e), after the PBS is added, the PBS solution will partially diffuse on the surface due to the hydrophilicity of the nanofiber membrane, and then the PBS solution will remain on the surface of the chitosan nanofiber membrane, and will not dissolve the chitosan nanofiber membrane to destroy the structural integrity of the fiber grid; the chitosan short fiber suspension is shown in Figure 1f, it can be seen that the suspension has uniform color and no clots; the microscopic morphology of the chitosan short fiber suspension was observed using an optical microscope, such as Figure 1 As shown in Figure g, it can be clearly seen that the short fibers are evenly distributed in the liquid, with consistent lengths, and there is overlap between the short fibers. The lengths of the short fibers were statistically analyzed ( Figure 1 h), the average length of the short fibers was 177.1±77.4 μm.

[0073] 3.2 Structure and composition of quaternary ammonium salt chitosan nanofiber hemostatic sponge

[0074] See the photo of quaternary ammonium salt chitosan nanofiber hemostatic sponge Figure 2 a; A sponge with a diameter of 1.5 cm and a height of 1.5 cm can stand on the dandelion hair, indicating that the quaternary ammonium salt chitosan nanofiber hemostatic sponge has the characteristics of ultra-lightness. The density of the sponge is calculated to be 11.0 mg / cm 3 , the porosity is about 93.03%; Figure 2 The SEM image of b shows that the outer surface of the quaternary ammonium salt chitosan nanofiber hemostatic sponge contains a large number of small holes formed by the overlapping of randomly arranged nanofibers; Figure 2 A large number of macropores can be clearly observed in the SEM image of c; Figure 2 d It can be seen that the outer surface and the inner nanofibers of the sponge are strongly connected through cross-linking points, which helps to maintain good mechanical stability; the pore sizes of two different scales were counted and it was found that the average pore size of the small pores on the outer surface was about 4.9 μm, while the average pore size of the large pores inside was about 22.6 μm ( Figure 2 e); the formation mechanism of the gradient pore structure is closely related to the freeze-drying process of the ice template. The cold source liquid nitrogen is at a very low temperature (-196°C). A container containing a quaternary ammonium chitosan nanofiber suspension is placed in the cold source, and a temperature gradient is rapidly formed between the inner wall and the center of the container. Due to the low temperature, small and stable ice crystals are formed in the quaternary ammonium chitosan nanofiber suspension near the inner wall of the container, while the temperature in the center of the container is higher, which is conducive to the formation of large ice crystals. After freeze-drying, a quaternary ammonium chitosan nanofiber hemostatic sponge with dense small pores on the outer surface and large pores on the inner surface is obtained.

[0075] The present invention introduces quaternary ammonium salt groups (-N +(CH3)3), enhancing the positive charge effect of chitosan nanofibers, thereby improving the electrostatic attraction with coagulation components such as red blood cells and platelets, helping to aggregate coagulation components and thus accelerate hemostasis. The structure of the quaternary ammonium salt chitosan nanofiber hemostatic sponge can be made stronger by crosslinking with glutaraldehyde solution steam. In order to prove the successful use of GMTAC for grafting modification, FTIR spectroscopy was performed on GMTAC and quaternary ammonium salt chitosan nanofiber hemostatic sponge, such as Figure 2 f, GTMAC at 1480cm -1 -N appears + The bending vibration peak of CH in (CH3)3 is weaker and appears at 1480 cm-1. -1 and -N + The bending vibration peak of CH in (CH3)3 showed that the quaternary ammonium salt chitosan nanofiber hemostatic sponge was successfully grafted and -N + (CH3)3 group.

[0076] 3.3 Liquid absorption performance of quaternary ammonium salt chitosan nanofiber hemostatic sponge

[0077] from Figure 3 a and b show that the quaternary ammonium chitosan nanofiber hemostatic sponge exhibits good hydrophilicity to both water and whole blood, and the contact angle to water is slightly larger than that to whole blood, indicating that the quaternary ammonium chitosan nanofiber hemostatic sponge has a stronger affinity to blood. The high affinity of the sponge to blood may be due to electrostatic attraction, because the sponge has a certain number of positively charged quaternary ammonium groups that can interact with negatively charged blood cells, resulting in a smaller contact angle between blood and water. The quaternary ammonium chitosan nanofiber hemostatic sponge was further placed in water and whole blood to observe the liquid transport performance, such as Figure 3 As shown in c and d, the sponge was placed in deionized water stained with methylene blue. Under the action of capillary force, the liquid gradually diffused 2 cm within 20 seconds. In contrast, the height and speed of blood transport were relatively low, which may be due to the higher viscosity of blood than water. The water / whole blood body absorption performance of the quaternary ammonium salt chitosan nanofiber hemostatic sponge was further measured, and the results are shown in Figure 3As shown in FIG. 4 , the sponge is first placed in water dyed with methylene blue, and it can quickly absorb a large amount of water. After the saturated sponge is compressed to discharge the absorbed water, it can quickly absorb the liquid and return to its original shape after the external force of compression is removed. Through the liquid absorption rate test, it can be found that the absorption capacity of the quaternary ammonium chitosan nanofiber hemostatic sponge for water and blood is approximately 93 and 73 g / g, respectively. The results of the cyclic liquid absorption capacity show that after continuous compression and absorption of liquid for 10 times, the sponge still has a high liquid absorption capacity of up to 81 g / g. Due to its unique porous structure and hydrophilicity, the quaternary ammonium chitosan nanofiber hemostatic sponge exhibits excellent, cyclic water / blood adsorption performance, which is of great significance for concentrating blood cells.

[0078] 3.4 Mechanical properties of quaternary ammonium salt chitosan nanofiber hemostatic sponge

[0079] The compression and resilience of quaternary ammonium salt chitosan nanofiber hemostatic sponge is particularly important for deep irregular bleeding, because it can form a physical barrier to the bleeding wound through the mechanical strength of the sponge to prevent bleeding. First, the compression and resilience of quaternary ammonium salt chitosan nanofiber hemostatic sponge was studied. Figure 4 As shown, the sponge is loaded into a compression needle tube and compressed by 80% by pressing. It can be found that the sponge can still restore its original shape after 10 compression cycles, indicating that the sponge has excellent structural stability and can maintain its original shape when applied to deep incompressible bleeding wounds to effectively stop bleeding.

[0080] 3.5 Filtration mechanism of quaternary ammonium chitosan nanofiber hemostatic sponge

[0081] The filtration mechanism of quaternary ammonium salt chitosan nanofiber hemostatic sponge was studied by SEM, and the outer surface of the sponge after filtration ( Figure 5 a) and the internal image of the sponge ( Figure 5 b). It can be found that a large number of red blood cells are gathered on the outer surface of the sponge, and some of the red blood cells are bound in the small holes formed by the fibers. In the interior of the sponge, only a small number of red blood cells exist, indicating that the quaternary ammonium salt chitosan nanofiber hemostatic sponge can effectively filter red blood cells on the sponge surface, thereby enriching red blood cells and accelerating the formation of blood clots. Based on the above results, it can be obtained as follows Figure 5 c is a diagram of the sponge filtration mechanism. Due to the unique small pore structure on the surface of the quaternary ammonium salt chitosan nanofiber hemostatic sponge and the charge effect of the quaternary ammonium salt group, when blood is dripped onto the sponge, the coagulation components can be filtered and captured, thereby enriching a large number of coagulation components on the surface to accelerate coagulation. The macroporous structure inside the sponge can improve the concentration efficiency and absorb the plasma in the blood into the internal macropores.

[0082] In order to prove that the quaternary ammonium salt chitosan nanofiber hemostatic sponge can simultaneously absorb liquid, concentrate, screen and filter when acting on incompressible bleeding wounds, thereby accelerating hemostasis. Figure 5 As shown in Figure d, the sponge is placed in whole blood, and it can be found that as time goes by, the light red plasma gradually spreads and rises on the sponge. After 30 seconds of contact, the sponge is picked up and it can be found that a relatively obvious blood clot has formed at the bottom of the sponge, and above the blood clot is light red plasma. This may be because when the quaternary ammonium chitosan nanofiber hemostatic sponge is placed in the blood, the high liquid absorption rate of the sponge can quickly absorb the liquid and absorb the plasma into the sponge. Due to the unique gradient pore structure of the sponge, the small pore structure on the surface can filter and capture the coagulation components in the blood, and the plasma is stored in the macroporous structure inside the sponge under the simultaneous action of filtration capture and liquid absorption concentration. In addition, the electrostatic attraction of QCS helps the aggregation of coagulation components. Under the action of multiple mechanisms, blood clots can be quickly formed on the surface of the material to quickly stop bleeding.

[0083] 3.6 In vitro antibacterial properties of sponges

[0084] The antibacterial properties of the sponge were analyzed using the plate counting method. Figure 6 As shown in a and b, it can be found that for the antibacterial results of Staphylococcus aureus, the control group has a large number of bacterial colonies, and the QCS group (i.e., the quaternary ammonium salt chitosan nanofiber hemostatic sponge group) has the least number of colonies. By counting the number of colonies and calculating the antibacterial rate, it can be found that the QCS group has a higher antibacterial rate (92.0%). Similar results were shown for Escherichia coli, such as Figure 6 c, while the QCS group had a high antibacterial rate of 89.3%.

[0085] 3.7 In vivo hemostatic properties of sponges

[0086] Using the rabbit carotid artery bleeding model ( Figure 7 (a) The hemostatic performance of quaternary ammonium salt chitosan nanofiber hemostatic sponge for fatal arterial bleeding was evaluated. Figure 7 As shown in b, gelatin sponge group ( ) and collagen sponge group ( ) After 240 seconds of action, blood continued to flow out of the two groups of sponges. However, the quaternary ammonium salt chitosan nanofiber hemostatic sponge in the QCS group could effectively control bleeding in about 60 seconds, and there was no bleeding afterwards. Further quantitative analysis of the hemostasis time and blood loss of different sponges (such as Figure 7c, d). The gelatin sponge and collagen sponge groups still could not control bleeding at 240s and showed a bleeding state. The quaternary ammonium chitosan nanofiber hemostatic sponge in the QCS group can effectively control bleeding in about 61.6s, and no bleeding occurs after hemostasis. The blood loss of the bleeding wound after 240s of treatment with the gelatin sponge and collagen sponge groups was about 44.0 and 36.7g, respectively, while the bleeding wound treated with the quaternary ammonium chitosan nanofiber hemostatic sponge in the QCS group showed the least blood loss, only about 5.0g. Compared with the gelatin sponge group, it can effectively reduce blood loss, reducing blood loss by about 8.8 times. This shows that the quaternary ammonium chitosan nanofiber hemostatic sponge still has excellent hemostatic ability for fatal bleeding, and can effectively shorten the hemostasis time and reduce blood loss.

[0087] Example 2

[0088] Preparation method of chitosan nanofiber hemostatic sponge with external filtration and internal absorption of quaternary ammonium salt

[0089] (1) Preparation of chitosan nanofiber membrane

[0090] 0.2g chitosan particles were added to 10mL mixed solvent of hexafluoroisopropanol (HFIP) and glacial acetic acid (HAC) in a ratio of 8:2 and stirred for 20h to obtain a translucent chitosan spinning solution. The chitosan spinning solution was electrospun at room temperature using an electrospinning device, with a spinning flow rate of 1.2mL / h; a spinning voltage of 18kV; a roller speed of 500r / min, and a spinning distance of 15cm between the needle and the roller. The nanofibers were collected using aluminum foil attached to the roller, and the non-volatile solvent was removed by vacuum drying in an oven to obtain a uniform chitosan nanofiber membrane. The experiment was repeated many times to obtain a large number of chitosan nanofiber membranes.

[0091] (2) Preparation of quaternary ammonium salt chitosan nanofiber hemostatic sponge

[0092] 0.5g of the chitosan nanofiber membrane obtained in step (1) was added to 50mL of water and crushed and homogenized to obtain a uniform and stable chitosan short fiber suspension. Then, the chitosan nanofiber was grafted with quaternary ammonium salt, and 0.2mol of 2,3-epoxypropyltrimethylammonium chloride (GTMAC) solid powder was added to the short fiber suspension with a chitosan nanofiber content of 0.05mol in molar ratio, and reacted at 75°C for 40h. Then, a centrifuge was used to centrifuge at 6000rpm for 10min to remove the unreacted 2,3-epoxypropyltrimethylammonium chloride (GTMAC) to obtain quaternary ammonium salt-grafted chitosan nanofibers. The quaternary ammonium salt-grafted chitosan nanofibers and solvent water were further prepared into a suspension with a solid content of 5%, which was poured into a container and frozen with liquid nitrogen until it became a block. Then the quaternary ammonium chitosan nanofiber hemostatic sponge is transferred to a vacuum freeze dryer and freeze-dried to obtain a quaternary ammonium chitosan nanofiber hemostatic sponge. The outer surface of the quaternary ammonium chitosan nanofiber hemostatic sponge contains a large number of small holes, which are composed of randomly arranged nanofibers overlapping each other, and the internal structure is a very large pore.

[0093] Example 3

[0094] Preparation method of chitosan nanofiber hemostatic sponge with external filtration and internal absorption of quaternary ammonium salt

[0095] (1) Preparation of chitosan nanofiber membrane

[0096] 0.2g chitosan particles were added to 10mL mixed solvent of hexafluoroisopropanol (HFIP) and glacial acetic acid (HAC) in a ratio of 9:1 and stirred for 20h to obtain a translucent chitosan spinning solution. The chitosan spinning solution was electrospun at room temperature using an electrospinning device, with a spinning flow rate of 2.0mL / h; a spinning voltage of 5kV; a roller speed of 100r / min, and a spinning distance of 5cm between the needle and the roller. The nanofibers were collected using aluminum foil attached to the roller, and the non-volatile solvent was removed by vacuum drying in an oven to obtain a uniform chitosan nanofiber membrane. The experiment was repeated many times to obtain a large amount of chitosan nanofiber membrane.

[0097] (2) Preparation of quaternary ammonium salt chitosan nanofiber hemostatic sponge

[0098] 10g of chitosan nanofiber membrane synthesized multiple times according to step (1) was added with 50mL of water, crushed and homogenized to obtain a uniform and stable chitosan short fiber suspension. Then, the chitosan nanofiber was grafted with quaternary ammonium salt, and 0.2mol of 2,3-epoxypropyltrimethylammonium chloride (GTMAC) solid powder was added to the short fiber suspension with a chitosan nanofiber content of 0.1mol in molar ratio, and reacted at 60°C for 40h. Then, a centrifuge was used to centrifuge at 6000rpm for 10min to remove the unreacted 2,3-epoxypropyltrimethylammonium chloride (GTMAC) to obtain quaternary ammonium salt-grafted chitosan nanofiber. The quaternary ammonium salt-grafted chitosan nanofiber and solvent water were further prepared into a suspension with a solid content of 0.5%, which was poured into a container and frozen with liquid nitrogen until it became a block. Then be transferred to the quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained by freeze drying in the vacuum freeze drier, the outer surface of the quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained contains a large amount of pores, and these pores are composed of the mutual overlap of randomly arranged nanofibers, and internal structure is a very large hole.Placing the quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained in mass percent is cross-linked in 1% glutaraldehyde solution steam, making the mutual overlap between the fiber inside the sponge improve the stability of structure, then sponge is removed residual glutaraldehyde solution steam in the sponge through vacuum drying, obtain the quaternary ammonium salt chitosan nanofiber hemostatic sponge with more stable structure.

[0099] Example 4

[0100] Preparation method of chitosan nanofiber hemostatic sponge with external filtration and internal absorption of quaternary ammonium salt

[0101] (1) Preparation of chitosan nanofiber membrane

[0102] 1.0g chitosan particles were added to 10mL mixed solvent of hexafluoroisopropanol (HFIP) and glacial acetic acid (HAC) in a ratio of 9:1 and stirred for 20h to obtain a translucent chitosan spinning solution. The chitosan spinning solution was electrospun at room temperature using an electrospinning device, with a spinning flow rate of 0.1mL / h; a spinning voltage of 30kV; a roller speed of 4000r / min, and a spinning distance of 20cm between the needle and the roller. The nanofibers were collected using aluminum foil attached to the roller, and the non-volatile solvent was removed by vacuum drying in an oven to obtain a uniform chitosan nanofiber membrane. The experiment was repeated many times to obtain a large number of chitosan nanofiber membranes.

[0103] (2) Preparation of quaternary ammonium salt chitosan nanofiber hemostatic sponge

[0104] After adding 50 mL of water to 0.1 g of the chitosan nanofiber membrane obtained in step (1), it was crushed and homogenized to obtain a uniform and stable chitosan short fiber suspension. Then, the chitosan nanofiber was grafted with quaternary ammonium salt, and 0.2 mol of 2,3-epoxypropyltrimethylammonium chloride (GTMAC) solid powder was added to the short fiber suspension with a chitosan nanofiber content of 0.1 mol in a molar ratio, and reacted at 85°C for 40 hours. Then, a centrifuge was used to centrifuge at 6000 rpm for 10 minutes to remove the unreacted 2,3-epoxypropyltrimethylammonium chloride (GTMAC) to obtain quaternary ammonium salt-grafted chitosan nanofibers. The quaternary ammonium salt-grafted chitosan nanofibers and solvent water were further prepared into a suspension with a solid content of 10%, which was poured into a container and frozen with liquid nitrogen until it became a block. Then be transferred to the quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained by freeze drying in the vacuum freeze drier, the outer surface of the quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained contains a large amount of pores, and these pores are composed of the mutual overlap of randomly arranged nanofibers, and internal structure is a very large hole.Placing the quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained in mass percent is cross-linked in 20% glutaraldehyde solution steam, making the mutual overlap between the fiber inside the sponge improve the stability of structure, then sponge is removed residual glutaraldehyde solution steam in the sponge through vacuum drying, obtain the quaternary ammonium salt chitosan nanofiber hemostatic sponge with more stable structure.

[0105] The quaternary ammonium salt chitosan nanofiber hemostatic sponge of the present invention has a gradient pore structure (small pores on the outer surface: 4.9 μm, large pores inside: 22.6 μm) and a high liquid absorption rate (93 g / g). When the sponge acts on a deep incompressible bleeding wound, firstly, due to the high liquid absorption characteristic of the sponge, the plasma in the blood will be quickly absorbed to achieve the purpose of aggregating platelets and red blood cells. Then, on the one hand, due to the small pore structure on the outer surface and the macroporous structure that is interconnected inside, the coagulation components (mainly red blood cells, platelets, etc.) in the blood will be screened and filtered. The coagulation components are further captured and aggregated on the surface of the quaternary ammonium salt chitosan nanofiber hemostatic sponge, and the plasma filtered into the inside of the sponge is stored in the macroporous structure inside the sponge. On the other hand, due to the grafting of the quaternary ammonium salt, the electrostatic attraction of the sponge is further enhanced, and the sponge can attract the coagulation components to aggregate on the sponge surface through the electrostatic action. Through the synergistic effect of the above multiple mechanisms, a large amount of coagulation components will be aggregated on the sponge surface, and then blood clots will be quickly formed, so as to achieve rapid hemostasis of incompressible bleeding. In contrast, the quaternary ammonium chitosan nanofiber hemostatic sponge simulates the framework structure of the fibrin network. After contacting the blood, it can quickly screen and capture the coagulation components, and then gather a large number of coagulation components to form a blood clot to quickly stop bleeding. Compared with the traditional coagulation mechanism, the quaternary ammonium chitosan nanofiber hemostatic sponge can quickly form a blood clot for hemostasis. It is independent of the body's coagulation cascade reaction and is not affected by blood diseases such as coagulation disorders, making it widely used in various types of wound bleeding.

[0106] The above contents are further detailed descriptions of the present invention in combination with specific preferred embodiments, and the specific implementation of the present invention cannot be limited to these descriptions. For ordinary technicians in the field to which the present invention belongs, several simple deductions or substitutions can be made without departing from the concept of the present invention, which should be regarded as falling within the protection scope of the present invention.

Claims

1. A method for preparing a quaternary ammonium salt chitosan nanofiber hemostatic sponge with external filtration and internal absorption, characterized in that: The steps include: (1) Preparation of chitosan nanofiber membrane The chitosan is dissolved in a mixed solvent of hexafluoroisopropanol and glacial acetic acid to obtain a chitosan spinning solution; the chitosan spinning solution is electrostatically spun using an electrostatic spinning device, and nanofibers are collected and dried to obtain a chitosan nanofiber membrane; (2) Preparation of quaternary ammonium salt chitosan nanofiber hemostatic sponge The chitosan nanofiber membrane obtained in step (1) is homogenized to obtain a chitosan short fiber suspension; 2,3-epoxypropyltrimethylammonium chloride is added to the chitosan short fiber suspension for heating reaction, and quaternary ammonium salt-grafted chitosan nanofibers are obtained by centrifugation; the quaternary ammonium salt-grafted chitosan nanofibers are added with a solvent to prepare a suspension, and then the suspension is poured into a container and frozen using a low-temperature cold source, and after complete freezing, it is transferred to a vacuum freeze dryer and freeze-dried to obtain a quaternary ammonium salt chitosan nanofiber hemostatic sponge.

2. The preparation method according to claim 1, characterized in that: In step (1), the volume ratio of hexafluoroisopropanol to glacial acetic acid is (8-9):(1-2).

3. The preparation method according to claim 1, characterized in that: In step (1), the mass volume ratio of chitosan to the mixed solvent is (0.2-1.0) g:10 mL.

4. The preparation method according to claim 1, characterized in that: In step (1), the chitosan spinning solution is electrospun at room temperature using an electrospinning device.

5. The preparation method according to claim 1, characterized in that: In step (1), during the electrospinning process, the spinning flow rate is (0.1-2.0) mL / h; the spinning voltage is (5-30) kV; the roller speed is (100-4000) r / min; the spinning distance is (5-20) cm from the needle to the roller; and the nanofibers are collected using aluminum foil attached to the roller.

6. The preparation method according to claim 1, characterized in that: In step (2), the solvent for homogenizing the chitosan nanofiber membrane is water, wherein the mass volume ratio of the chitosan nanofiber membrane to the solvent is (0.1-10.0) g:50 mL; the molar ratio of 2,3-epoxypropyltrimethylammonium chloride to the chitosan short fibers in the chitosan short fiber suspension is 2:(0.5-1).

7. The preparation method according to claim 1, characterized in that: In step (2), the temperature of the heating reaction is 60-85° C., and the reaction time is 1-40 hours; in the process of adding the chitosan nanofibers grafted with quaternary ammonium salt into a solvent to prepare a suspension, the solid content of the suspension is 0.1%-10.0%, and the solvent is water; the low-temperature cooling source is liquid nitrogen.

8. The preparation method according to claim 1, characterized in that: The method also includes placing the obtained quaternary ammonium salt chitosan nanofiber hemostatic sponge in the vapor of 1% to 50% by mass of glutaraldehyde solution for cross-linking, so that the fibers inside the sponge overlap with each other to improve the stability of the structure, and then vacuum drying the sponge to remove the residual glutaraldehyde solution vapor in the sponge to obtain a quaternary ammonium salt chitosan nanofiber hemostatic sponge with a more stable structure.

9. The quaternary ammonium salt chitosan nanofiber hemostatic sponge obtained by the method according to any one of claims 1 to 8, characterized in that: The quaternary ammonium salt chitosan nanofiber hemostatic sponge has a gradient pore structure with different pore diameters inside and outside.

10. The quaternary ammonium salt chitosan nanofiber hemostatic sponge according to claim 9, characterized in that: The outer surface of the quaternary ammonium chitosan nanofiber hemostatic sponge contains a large number of small pore structures formed by randomly arranged quaternary ammonium chitosan nanofibers overlapping each other, and the external small pores can filter coagulation components; the internal structure of the quaternary ammonium chitosan nanofiber hemostatic sponge is a large number of large pore structures, and the internal large pores make the hemostatic sponge have an ultra-high liquid absorption rate.

Citation Information

Cited By

  • Collagen hemostatic sponge with composite pore structure and preparation method of collagen hemostatic sponge

    CN119455067A

  • Chitosan quaternary ammonium salt sponge capable of rapidly coagulating blood and preparation method of chitosan quaternary ammonium salt sponge

    CN120919380A